Synthesis of novel melanocortin 4 receptor agonists and antagonists containing a succinamide core.

[1]  Michael G Kelly,et al.  Design of a new peptidomimetic agonist for the melanocortin receptors based on the solution structure of the peptide ligand, Ac-Nle-cyclo[Asp-Pro-DPhe-Arg-Trp-Lys]-NH(2). , 2003, Bioorganic & medicinal chemistry letters.

[2]  D. Johnston,et al.  Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonist. , 2002, Journal of medicinal chemistry.

[3]  T. Ando,et al.  2a-[4-(Tetrahydropyridoindol-2-yl)butyl]tetrahydrobenzindole derivatives: new selective antagonists of the 5-hydroxytryptamine7 receptor. , 2002, Journal of medicinal chemistry.

[4]  A. Turnbull,et al.  Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. , 2002, The Journal of endocrinology.

[5]  Terry Kenakin,et al.  Efficacy at g-protein-coupled receptors , 2002, Nature Reviews Drug Discovery.

[6]  J Lindblom,et al.  New aspects on the melanocortins and their receptors. , 2000, Pharmacological research.

[7]  J. Metzger,et al.  Role of the melanocortin-4 receptor in metabolic rate and food intake in mice , 2000, Transgenic Research.

[8]  J. Wikberg,et al.  Melanocortin receptors: perspectives for novel drugs. , 1999, European journal of pharmacology.

[9]  V. Hruby,et al.  Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study. , 1998, The Journal of urology.

[10]  H. Broughton,et al.  Serine derived NK1 antagonists. 2: A pharmacophore model for arylsulfonamide binding. , 1998, Bioorganic & medicinal chemistry letters.

[11]  Victor J. Hruby,et al.  Role of melanocortinergic neurons in feeding and the agouti obesity syndrome , 1997, Nature.

[12]  V. Hruby,et al.  Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics. , 1989, Journal of medicinal chemistry.

[13]  V. Hruby,et al.  Amino acid mimetics and design of peptidomimetics for opioid and melanocortin receptors: General perspectives , 1999 .

[14]  Davidr . Evans,et al.  1 – Stereoselective Alkylation Reactions of Chiral Metal Enolates , 1984 .